Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1357259-11-0

C20H20BrN3O4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1357259-11-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1357259-11-0 Structure

  • Basic information

    1. Product Name: C20H20BrN3O4
    2. Synonyms: C20H20BrN3O4
    3. CAS NO:1357259-11-0
    4. Molecular Formula:
    5. Molecular Weight: 446.3
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1357259-11-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C20H20BrN3O4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C20H20BrN3O4(1357259-11-0)
    11. EPA Substance Registry System: C20H20BrN3O4(1357259-11-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1357259-11-0(Hazardous Substances Data)

1357259-11-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1357259-11-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,7,2,5 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1357259-11:
(9*1)+(8*3)+(7*5)+(6*7)+(5*2)+(4*5)+(3*9)+(2*1)+(1*1)=170
170 % 10 = 0
So 1357259-11-0 is a valid CAS Registry Number.

1357259-11-0Relevant articles and documents

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

-

Page/Page column 27, (2013/07/19)

Inhibitors of HCV replication of formula I, including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R' have the meaning as defined herein. The present invention also relates to processes for preparing said compounds

QUINAZOLINONE DERIVATIVES AS HCV INHIBITORS

-

Page/Page column 27, (2013/07/19)

Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, salts, and solvates thereof, wherein R and R' have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

-

, (2012/02/13)

Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R' have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors,in HCV therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1357259-11-0